Orth K, König K, Genze F, Rück A
Department of General Surgery University of Ulm, Germany.
J Cancer Res Clin Oncol. 1994;120(11):657-61. doi: 10.1007/BF01245377.
5-Aminolevulinic acid (5-ALA) is a precursor in the biosynthesis of haem. External application of 5-ALA leads to the formation of protoporphyrin IX, the last intermediate product before haem, which is an effective sensitiser. The 5-ALA-induced endogenous photosensitisation of tumour cells has been exploited for photodynamic therapy (PDT). Experimental human G-3 colonic tumours were transplanted into nude mice, and ten mice were treated by PDT. Ten animals served as controls. We measured a fluorescence intensity of the tumour that was about eight times higher than in the surrounding tissue; a good correlation between the fluorescence intensity and the photodynamic effect was found. Tumour growth was inhibited significantly after PDT, two tumours being destroyed completely after the second PDT treatment. In addition, on-line fluorescence detection during PDT showed a change in the intensity and the fluorescence spectrum of protoporphyrin IX caused by photobleaching and the formation of photoproducts.
5-氨基乙酰丙酸(5-ALA)是血红素生物合成的前体。外用5-ALA会导致原卟啉IX的形成,原卟啉IX是血红素之前的最后一种中间产物,是一种有效的敏化剂。5-ALA诱导的肿瘤细胞内源性光致敏作用已被用于光动力疗法(PDT)。将实验性人类G-3结肠肿瘤移植到裸鼠体内,10只小鼠接受了PDT治疗。10只动物作为对照。我们测量到肿瘤的荧光强度比周围组织高约8倍;发现荧光强度与光动力效应之间有良好的相关性。PDT后肿瘤生长受到显著抑制,第二次PDT治疗后有两个肿瘤被完全破坏。此外,PDT期间的在线荧光检测显示,光漂白和光产物的形成导致原卟啉IX的强度和荧光光谱发生变化。